The US accounts for an estimated 5.5 percent of the global dry eye
population, but its dry eye market accounts for 32.7 percent of units.
- Florida and Texas have a high concentration of residents in the target patient profile.
- New York, Los Angeles, and Chicago have a high volume of dry eye patients, while Dallas and Atlanta have a high-opportunity population.
- New England has the smallest share of the US dry eye population.
- Opportunity in the Midwest varies greatly among metros.
Dry eye population allocation is calculated by combining prevalence rates, IOL surgeries, and LVC
procedures from Market Scope models.
Geographic opportunity is estimated with multi-factor criteria using Market Scope's Med/Op
Index™. The index is derived from multiple sources, including the following:
- Market Scope's proprietary dry eye, refractive, and cataract models
- CMS procedure and prescription data
- US Census and US Office of Management and Budget
‘The 2019 United States Dry Eye Atlas’, new in 2019, provides a detailed analysis of the dry
eye market. Market Scope's proprietary Med/Op Index™ identifies the potential based on a
variety of factors, which allows us to rank metros by ooportunity. The atlas offers strategic
insights into the top potential markets in the US.
Featured in the atlas is the Med/Op Index™, a proprietary new index developed to estimate
the market opportunity for in each metropolitan area. This proprietary index identifies the
potential based on key demographics, climate, health, post LVC, pseudophakic, and wealth.
The Dry Eye Atlas can be used to evaluate market potential and to allocate sales resources.
Market Scope also offers customization of this information to align with a client sales
organization or specific geographic areas.
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house
consultants/analysts with over 100 years of collective ophthalmic experience, and each data
point is driven by a combination of sources, including the following:
- Our proprietary global disease population and demographic models
- Twenty years and counting of ophthalmologist survey data
- Analysis of company published financial reports
- Focused coverage of ophthalmic scientific research, business news, and other activities
- Attendance and participation in major, worldwide ophthalmic meetings
- Interviews and long-standing relationships with company executives and practicing ophthalmologists
Chelsea joined Market Scope in June 2017 as the manager of analytics and modeling; she manages the data team, constructs data models, and drives the overall analytics strategy at Market Scope. After receiving her MBA, Chelsea began her career at Cerner Corporation, the leading supplier of health care information technology solutions, where she performed many analytical roles in the Population Health organization. She also has experience in crafting and executing competitive intelligence strategy. When Chelsea is not working, she enjoys thrift-shopping with her three daughters, solving data problems with her husband, wrestling with her dogs, traveling, and weight lifting.
Table of Contents
The atlas offers an in-depth examination of the dry eye population, and Market Scope's Med/Op Index™ integrates all variables to illustrate US market opportunity by metro area.
The following information is included for 85 metropolitan areas:
Key demographic information
- Age allocation
- Gender allocation
- Household income
Dry eye population
- Dry eye population likely to seek treatment
- Dry eye population by severity: episodic, moderate, severe
- Dry eye population by diagnostic category: aqueous deficient, MGD, both
- Total ophthalmologists: cataract surgeons, refractive surgeons, combo cataract/refractive surgeons
- Total optometrists: optometrists prescribing, optometrist prescribing for dry eye
Estimated LVC procedures of selected metropolitan areas
Estimated IOL and premium IOL procedures of selected metropolitan areas